| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.15B | 89.66B | 88.85B | 82.32B | 71.50B | 63.21B |
| Gross Profit | 17.40B | 16.59B | 15.09B | 12.88B | 11.51B | 9.42B |
| EBITDA | 9.55B | 9.69B | 8.98B | 8.14B | 7.02B | 5.87B |
| Net Income | 2.69B | 2.93B | 3.05B | 2.13B | 2.08B | 1.25B |
Balance Sheet | ||||||
| Total Assets | 75.58B | 79.40B | 76.03B | 71.53B | 65.04B | 63.82B |
| Cash, Cash Equivalents and Short-Term Investments | 10.69B | 12.42B | 12.01B | 9.97B | 9.30B | 8.99B |
| Total Debt | 11.10B | 12.66B | 12.46B | 13.59B | 11.54B | 12.36B |
| Total Liabilities | 31.54B | 33.46B | 34.02B | 33.57B | 30.66B | 31.49B |
| Stockholders Equity | 41.46B | 43.27B | 39.54B | 35.62B | 32.23B | 30.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 830.00M | 4.36B | -1.14B | 2.45B | 366.00M |
| Operating Cash Flow | 0.00 | 6.63B | 8.84B | 3.52B | 5.34B | 4.75B |
| Investing Cash Flow | 0.00 | -5.83B | -4.47B | -3.99B | -2.85B | -4.03B |
| Financing Cash Flow | 0.00 | -640.00M | -2.78B | 753.00M | -2.81B | -859.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥81.75B | 10.30 | ― | 3.85% | -4.47% | 29.68% | |
77 Outperform | ¥26.47B | 14.38 | ― | 4.20% | -1.15% | -34.09% | |
75 Outperform | ¥489.07B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
73 Outperform | ¥143.29B | 16.04 | ― | 5.78% | -4.26% | 17.85% | |
70 Outperform | ¥6.49B | 5.89 | ― | 2.64% | 2.28% | 41.72% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥3.70B | 10.35 | ― | 3.03% | 4.17% | -693.96% |